Organism: human
Disease: colorectal cancer
Disease: rectal cancer
AnatomicSiteTumor: rectum
TumorStage: T3
TumorStage: T4
TumorStage: N1
TumorStage: N2
TumorStage: stage IIA
TumorStage: stage IIIA
TumorStage: stage IIIB
TumorStage: stage IIIC
TumorGrade: well differentiated
TumorGrade: moderately differentiated
SampleTreatment: formalin-fixed paraffin-embedded (FFPE)
SampleTreatment: fixed in formalin
SampleTreatment: degreased and dehydrated
SampleTreatment: stained with haematoxylin and eosin (H&E)
SampleTreatment: dewaxing, homogenisation and concentration
SampleTreatment: reduction with dithiothreitol
SampleTreatment: alkylation with iodoacetamide
SampleTreatment: washed with acetonitrile
SampleTreatment: digested in Trypsin Gold
SampleTreatment: desalted using C18 column Zip-Tip
ReductionReagent: dithiothreitol
AlkylationReagent: iodoacetamide
CleavageAgent: trypsin
CleavageAgent: Trypsin Gold
Label: carbamidomethylation on cysteine
Label: methionine oxidation
Label: protein N-terminal acetylation
Modification: methionine oxidation
Modification: protein N-terminal acetylation
MaterialType: FFPE biopsies
MaterialType: tumor proteome
Separation: Acclaim PepMap100 C18 column (0.3 mm id x 5 mm)
Separation: PepMap C18 nanocolumn (75 microm x 50 cm)
Separation: linear gradient of 5–35% solvent B over 240 min
FlowRateChromatogram: 200 nL/min
FlowRateChromatogram: 4 microL/min
Instrument: OrbiTrap QExactive mass spectrometer
IonizationType: EasySpray source
AcquisitionMethod: collision induced dissociation
AcquisitionMethod: HPLC-MS/MS
FragmentationMethod: collision induced dissociation
CollisionEnergy: normalized collision energy 35%
MS2MassAnalyzer: Orbitrap
PrecursorMassTolerance: 7 ppm
FragmentMassTolerance: 20 ppm
NumberOfMissedCleavages: 2 miscleavages allowed
AssayName: proteomic profiling
AssayName: mass spectrometry
AssayName: quantitative proteomic approach
FactorValue: treatment response groups (NR, PR, TR)
TechnicalReplicate: duplicate biopsy
Age: median age was 58.6 ± 11.1 years (31–75)
Sex: 19 were men (83%) and 4 were women (17%)